Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment

Background: The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and mechanisms underlying different responses to systemic glucocorticoids (GC) remain unclear. The major aim of this study was to explore the transcriptomic and oxidative lipidomic signatures and the effects of GC in p...

全面介绍

书目详细资料
Main Authors: Zhenzhen Zhu, Weiqing Wang, Yang Zha, Xiaowei Wang, Lei Wang, Jinbo Han, Jianmin Zhang, Wei Lv
格式: 文件
语言:English
出版: Frontiers Media S.A. 2022-01-01
丛编:Frontiers in Pharmacology
主题:
在线阅读:https://www.frontiersin.org/articles/10.3389/fphar.2021.814953/full
_version_ 1831695600216702976
author Zhenzhen Zhu
Weiqing Wang
Yang Zha
Xiaowei Wang
Lei Wang
Jinbo Han
Jianmin Zhang
Wei Lv
author_facet Zhenzhen Zhu
Weiqing Wang
Yang Zha
Xiaowei Wang
Lei Wang
Jinbo Han
Jianmin Zhang
Wei Lv
author_sort Zhenzhen Zhu
collection DOAJ
description Background: The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and mechanisms underlying different responses to systemic glucocorticoids (GC) remain unclear. The major aim of this study was to explore the transcriptomic and oxidative lipidomic signatures and the effects of GC in patients with different clinical responses.Methods: Nasal polyp biopsies were obtained before and after 14-day oral GC treatment from 16 patients with CRSwNP, and normal nasal mucosa specimens were collected from 12 control subjects. RNA sequencing and oxidative lipidomics were performed, and differential gene expression analysis was conducted in the Responder and Non-responder groups at baseline and after treatment.Results: In the Responder group, GC significantly improved clinical symptoms and reduced tissue eosinophil infiltration. Meanwhile, GC led to a pronounced transcriptomic reversion with robust suppression of inflammatory responses and abnormal metabolism of extracellular matrix, as well as restoration of cilia function. However, non-responders were mainly characterized by epithelial hyperplasia and keratinization, with much less transcriptomic improvement after GC treatment. Higher expression of type 2 inflammatory molecules (CCL13, IGHE, CCL18, CCL23, CCR3, and CLC) with lower levels of LACRT, PPDPFL, DES, C6, MUC5B, and SCGB3A1 were related to a stronger clinical response to GC. Besides decreased prostaglandins and increased leukotrienes, increased dysregulation in other oxylipid mediators derived from polyunsaturated fatty acids was determined in nasal polyps, which was ameliorated by GC treatment.Conclusion: Systemic GC exert anti-inflammatory effects, improve tissue remodeling, restore cilia function, and ameliorate dysregulation of oxylipid mediator pathway in CRSwNP. GC-responders exhibited different transcriptomic signatures from non-responders.
first_indexed 2024-12-20T12:57:50Z
format Article
id doaj.art-a84d94e3e7cf4881a0ae0c55c4fd5f50
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-20T12:57:50Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-a84d94e3e7cf4881a0ae0c55c4fd5f502022-12-21T19:40:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-01-011210.3389/fphar.2021.814953814953Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After TreatmentZhenzhen Zhu0Weiqing Wang1Yang Zha2Xiaowei Wang3Lei Wang4Jinbo Han5Jianmin Zhang6Wei Lv7Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaState Key Laboratory of Medical Molecular Biology, Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, ChinaBackground: The pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP) and mechanisms underlying different responses to systemic glucocorticoids (GC) remain unclear. The major aim of this study was to explore the transcriptomic and oxidative lipidomic signatures and the effects of GC in patients with different clinical responses.Methods: Nasal polyp biopsies were obtained before and after 14-day oral GC treatment from 16 patients with CRSwNP, and normal nasal mucosa specimens were collected from 12 control subjects. RNA sequencing and oxidative lipidomics were performed, and differential gene expression analysis was conducted in the Responder and Non-responder groups at baseline and after treatment.Results: In the Responder group, GC significantly improved clinical symptoms and reduced tissue eosinophil infiltration. Meanwhile, GC led to a pronounced transcriptomic reversion with robust suppression of inflammatory responses and abnormal metabolism of extracellular matrix, as well as restoration of cilia function. However, non-responders were mainly characterized by epithelial hyperplasia and keratinization, with much less transcriptomic improvement after GC treatment. Higher expression of type 2 inflammatory molecules (CCL13, IGHE, CCL18, CCL23, CCR3, and CLC) with lower levels of LACRT, PPDPFL, DES, C6, MUC5B, and SCGB3A1 were related to a stronger clinical response to GC. Besides decreased prostaglandins and increased leukotrienes, increased dysregulation in other oxylipid mediators derived from polyunsaturated fatty acids was determined in nasal polyps, which was ameliorated by GC treatment.Conclusion: Systemic GC exert anti-inflammatory effects, improve tissue remodeling, restore cilia function, and ameliorate dysregulation of oxylipid mediator pathway in CRSwNP. GC-responders exhibited different transcriptomic signatures from non-responders.https://www.frontiersin.org/articles/10.3389/fphar.2021.814953/fullchronic rhinosinusitis with nasal polypsciliaglucocorticoidsoxylipid mediatortranscriptomic sequencing
spellingShingle Zhenzhen Zhu
Weiqing Wang
Yang Zha
Xiaowei Wang
Lei Wang
Jinbo Han
Jianmin Zhang
Wei Lv
Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
Frontiers in Pharmacology
chronic rhinosinusitis with nasal polyps
cilia
glucocorticoids
oxylipid mediator
transcriptomic sequencing
title Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
title_full Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
title_fullStr Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
title_full_unstemmed Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
title_short Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
title_sort transcriptomic and lipidomic profiles in nasal polyps of glucocorticoid responders and non responders before and after treatment
topic chronic rhinosinusitis with nasal polyps
cilia
glucocorticoids
oxylipid mediator
transcriptomic sequencing
url https://www.frontiersin.org/articles/10.3389/fphar.2021.814953/full
work_keys_str_mv AT zhenzhenzhu transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT weiqingwang transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT yangzha transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT xiaoweiwang transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT leiwang transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT jinbohan transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT jianminzhang transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment
AT weilv transcriptomicandlipidomicprofilesinnasalpolypsofglucocorticoidrespondersandnonrespondersbeforeandaftertreatment